跳至主要内容
临床试验/CTRI/2024/08/071896
CTRI/2024/08/071896已完成不适用

SINGLE ARM CLINICAL TRIAL TO ASSESS THE EFFICACY OF DASHMOOLA GHRITA MARSHA NASYA IN MIGRAINE IN RELATION TO CGRP BIOMARKER

Dr HIMANI BINJI1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2024年9月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
13
试验地点
1
主要终点
CGRP level

研究概览

简要总结

Migraine is correlated with Ardhavabhedaka in ayurveda and the line of treatment of ardhavabhedhaka is nasya.

In Migraineurs CGRP level is found elevated

Efficacy of Dashmoola Ghrita Marsha nasya has already been proved in Migraine

The efficicay of dashmoola ghrita marsha nasya in Migraine has been studied but in relation to CGRP biomarker has not been studied. Hence this study is proposed.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • •Participants who fits the Diagnostic criteria according to American Headache Society.
  • •Migraine disability assessment score (MIDAS) is above
  • •Participants who fits Nasya Karma.

排除标准

  • •Secondary headaches due to an underlying condition, such as trauma, infection, vascular disorders.
  • •Pregnant and lactating women.

结局指标

主要结局

CGRP level

时间窗: 0th day (screening) | 7th day (after the treatment) | 14th day (follow up)

Migraine Disability Assessment Score

时间窗: 0th day (screening) | 7th day (after the treatment) | 14th day (follow up)

次要结局

  • Migraine Assessment Disability Score is assessed before (0th day), after (7th day) and follow up (14th day) and Quality of Life assessment is done.(0th day (screenning))

研究者

发起方
Dr HIMANI BINJI
申办方类型
Other [Self ]
责任方
Principal Investigator
主要研究者

DR HIMANI BINJI

Amrita School of Ayurveda

研究点 (1)

Loading locations...

相似试验

TO ASSESS THE EFFICACY OF DASHMOOLA GHRITA NASYA IN... | 临床试验